Cita APA

Bhatt, P., Puente Maestu, L., & Abdulai, R. (2023). Dupilumab for COPD with Type 2 Inflammation Indicated by Eosinophil Counts.

Citación estilo Chicago

Bhatt, P., Luis Puente Maestu, y R.M Abdulai. Dupilumab for COPD With Type 2 Inflammation Indicated By Eosinophil Counts. 2023.

Cita MLA

Bhatt, P., Luis Puente Maestu, y R.M Abdulai. Dupilumab for COPD With Type 2 Inflammation Indicated By Eosinophil Counts. 2023.